Apolipoprotein E4 Genotype and Depressive Symptoms as Risk Factors for Dementia in an Older Korean Population

Abstract

ObjectiveGrowing evidence suggests the separate associations of apolipoprotein E e4 allele (apo E4) and depression with incident dementia. This study investigated the separate and combined effects of apo E4 and depression on the incidence of dementia in both men and women.MethodsOf 625 elderly without dementia at baseline, 518 (83%) were followed over a 2.4-year period and were assessed clinically for incident dementia. The apo E polymorphism was ascertained, and depression was identified using the Korean version of the Geriatric Depression Scale (KGDS). Covariates included age, gender, education, disability, alcohol history, physical activity, and vascular risk factors.ResultsThe incidence of dementia was significantly higher in elderly Koreans with both apo E4 and depression compared to those without both factors [adjusted odds ratio (95% CI)=5.85 (1.77-19.38)]. This interaction was significant in men (p=0.049), but not in women (p=0.354).ConclusionDepressed elderly people are at great risk for incident dementia in the presence of apo E4. Potential gender differences require further evaluation.

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late‐Onset Alzheimer′s Disease: Focus on APOE Gene

“…These findings were confirmed in two very recent longitudinal population-based studies [46, 47]. A recent study suggested that depression and APOE ε 4 genotype may be higher in women with AD but not in men [48].…”

Depression subtypes and 5‐year risk of dementia and Alzheimer disease in patients aged 70 years

“…Finally, Baldwin et al , () described an association between late‐onset depression and vascular dementia. Other authors reported that Apolipoprotein E ε4 presence increases the risk of developing AD in men (Irie et al , ) and not in women (Kim et al , ). Our results support late‐onset depressions, both MDDIS and MD, with DEDS as risk factors for dementia and AD.…”

Neurodegeneration, β‐amyloid and mood disorders: state of the art and future perspectives

“…Moreover, depression has repeatedly been shown to be a risk factor for baseline normal cognition or MCI progressing to a full‐blown diagnosis of Alzheimer's dementia (Cui et al ., ; Boyle et al ., ; Kim et al ., ; Kohler et al ., ; Rosenberg et al ., ; Singh‐Manoux et al ., ). Comparing patients affected by mood disorders and age‐matched healthy controls, acceleration in cognitive decline was found in patients over 65 years old (Gualtieri and Johnson, ).…”